TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31195195

Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive agricultural program
Number of subjects: 0
Study: 28266082

Group type: EXPERIMENTAL
Intervention: 500 mg of EGCG daily until full term
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study: 26398484

Group type: EXPERIMENTAL
Intervention: Visuospatial working memory training (adaptive n-back spatial task)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-adaptive version of n-back task (control group)
Number of subjects: 48
Study: 23641215

Group type: EXPERIMENTAL
Intervention: GSK1440115 (750 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 21434335

Group type: EXPERIMENTAL
Intervention: Danhong Injection (DHI) combined with conventional therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 70
Study: 19162515

Group type: EXPERIMENTAL
Intervention: Combined intermittent pneumatic leg compression and pharmacological prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single modalities (either intermittent pneumatic leg compression or pharmacological prophylaxis alone)
Number of subjects: 0
Study: 16831525

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 40

Group type: COMPARATOR
Intervention: 17beta-estradiol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 15088036

Group type: EXPERIMENTAL
Intervention: Light‐cured compomer with light‐cured dental adhesive
Number of subjects: 34

Group type: COMPARATOR
Intervention: Chemically cured glass ionomer
Number of subjects: 34
Study: 11334133

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS) such as beclomethasone, budesonide, and fluticasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0
Study: 10969345

Group type: EXPERIMENTAL
Intervention: Women (HIV-1 RNA levels)
Number of subjects: 3859

Group type: EXPERIMENTAL
Intervention: Nonwhites (HIV-1 RNA levels)
Number of subjects: 3859

Group type: EXPERIMENTAL
Intervention: Persons with a history of injection drug use (HIV-1 RNA levels)
Number of subjects: 3859

Group type: EXPERIMENTAL
Intervention: Women (CD4+ cell count decline)
Number of subjects: 3859

Group type: EXPERIMENTAL
Intervention: Nonwhites (CD4+ cell count decline)
Number of subjects: 3859
Study: 9351739

Group type: EXPERIMENTAL
Intervention: Tranilast
Number of subjects: 192
Study: 1479324

Group type: EXPERIMENTAL
Intervention: Cervical screening invitation in advance with breast screening invitation (group 1)
Number of subjects: 2131

Group type: COMPARATOR
Intervention: Breast screening only with cervical smear test offered upon arrival (group 2)
Number of subjects: 2131

Group type: COMPARATOR
Intervention: Overall attendance for breast screening
Number of subjects: 2131

Group type: EXPERIMENTAL
Intervention: Cervical screening among those attending breast screening
Number of subjects: 2131

Group type: EXPERIMENTAL
Intervention: Cervical smear test overdue
Number of subjects: 2131
Study: 3922903

Group type: EXPERIMENTAL
Intervention: TTS 10 (10 mg nitroglycerin over 24 hours)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: ISDN (20 mg slow-release)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30468108

Group type: EXPERIMENTAL
Intervention: Substance use prior to imprisonment; Alcohol (73%), Cigarettes (71%), Illicit drug use (27%), Injectable drug use (11%)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Intercourse with sex workers; 204 inmates reported having intercourse with sex workers
Number of subjects: 434
Study: 27126398

Group type: EXPERIMENTAL
Intervention: Trauma-focused psychotherapies (TFPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sertraline, venlafaxine, nefazodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paroxetine, fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venlafaxine, stress inoculation training (SIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bupropion, citalopram, divalproex, mirtazapine, tiagabine, topiramate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aripiprazole, divalproex, guanfacine, olanzapine (combined with an antidepressant)
Number of subjects: 0
Study: 24816151

Group type: EXPERIMENTAL
Intervention: Standard vest plus retroreflective strips positioned on the extremities in a configuration that conveyed biological motion (biomotion)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard road worker vest
Number of subjects: 24
Study: 23093479

Group type: EXPERIMENTAL
Intervention: Ketorolac/hyoscine butylbromide (10 mg/20 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Hyoscine butylbromide (20 mg)
Number of subjects: 160
Study: 20485915

Group type: EXPERIMENTAL
Intervention: Non-oily capsules containing vitamin D3 66,000 UI plus vitamin A 13,200 UI
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oily drops containing vitamin D3 66,000 UI plus vitamin A 13,200 UI
Number of subjects: 18
Study: 18589718

Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg two times a day)
Number of subjects: 40
Study: 15895289

Group type: EXPERIMENTAL
Intervention: LED irradiation (2 min at a continuous power output of 160 mW, radiant exposure of 1.07 J/cm(2))
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham irradiation (placebo)
Number of subjects: 64
Study: 11929403

Group type: EXPERIMENTAL
Intervention: Pantoprazole 10 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 36
Study: 10555738

Group type: EXPERIMENTAL
Intervention: Rigid Gas Permeable (RGP) lenses
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Soft contact lenses
Number of subjects: 29
Study: 7674186

Group type: EXPERIMENTAL
Intervention: Zinc phosphate cement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement with a dentinal bonding agent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 2174321

Group type: EXPERIMENTAL
Intervention: High carbohydrate meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: High fat meal
Number of subjects: 9
Study: 31736022

Group type: EXPERIMENTAL
Intervention: Intraperitoneal levobupivacaine 20 mL
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Incisional levobupivacaine 20 mL
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intraperitoneal + Incisional levobupivacaine 20 mL each
Number of subjects: 3
Study: 30620869

Group type: EXPERIMENTAL
Intervention: Dual Zinc plus Arginine dentifrice (0.96% zinc oxide, 1.5% Arginine, 1450 ppm fluoride)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regular fluoride dentifrice (1450 ppm fluoride)
Number of subjects: 100
Study: 26026183

Group type: EXPERIMENTAL
Intervention: Interactive videophone communication
Number of subjects: 68

Group type: COMPARATOR
Intervention: Individualized printed communication
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (printed and videophone)
Number of subjects: 68
Study: 24447269

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 16
Study: 22767584

Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide 100 mg/m(2) for 14 consecutive days in six 28-day cycles (CMF)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Standard chemotherapy (CMF or AC, provider/patient choice)
Number of subjects: 317
Study: 19925626

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (6 mg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Subcutaneous sumatriptan (6 mg) with MAOI-A
Number of subjects: 1000
Study: 18666395

Group type: EXPERIMENTAL
Intervention: Fluocinonide cream 0.1%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clobetasol propionate cream 0.05%
Number of subjects: 20
Study: 16424840

Group type: EXPERIMENTAL
Intervention: Less incision retroperitoneal approach (group-L), incision length 11.9±1.8 cm
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional incision (group-C), incision length 17.8±1.9 cm
Number of subjects: 27
Study: 12840180

Group type: EXPERIMENTAL
Intervention: Dietary EPA+DHA (0.8 or 1.7g/d)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dietary ALA (4.5 or 9.5g/d)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (linoleic acid; LA)
Number of subjects: 150
Study: 11789185

Group type: EXPERIMENTAL
Intervention: Danzhi Xiaoyao powder (DZXY) with conventional therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 51
Study: 8689878

Group type: EXPERIMENTAL
Intervention: Advantage 24
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conceptrol
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sponge
Number of subjects: 33
Study: 1739355

Group type: EXPERIMENTAL
Intervention: Imipenem plus amikacin
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus amikacin
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 750
Study: 6391333

Group type: EXPERIMENTAL
Intervention: 0.03% topical flurbiprofen
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine preoperative dilating drops (Control)
Number of subjects: 34
Study: 31771601

Group type: EXPERIMENTAL
Intervention: PEP-DC (autologous dendritic cells pulsed with personalized peptides)
Number of subjects: 0

Group type: COMPARATOR
Intervention: OC-DC (autologous dendritic cells loaded with oxidized tumor lysate)
Number of subjects: 0
Study: 30049462

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac Troponin-T (hs-cTnT)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Creatine kinase MB iso-enzyme (CKMB)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: N-terminal pro B-type Natriuretic Peptide (NT-proBNP)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Peak hs-cTnT
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Early EF
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: IS and EF at 4 ± 2 days
Number of subjects: 119
Study: 27366013

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 300 mg once daily for 12 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 24184169

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 10939

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 10939
Study: 22267243

Group type: EXPERIMENTAL
Intervention: Endurance exercise training for 4 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 120
Study: 19328328

Group type: EXPERIMENTAL
Intervention: FNGS 2.0
Number of subjects: 21

Group type: COMPARATOR
Intervention: Original FNGS
Number of subjects: 21
Study: 18156665

Group type: EXPERIMENTAL
Intervention: Amino acid/creatine/energy supplement (S)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Maltodextrin placebo (P)
Number of subjects: 8
Study: 15889114

Group type: EXPERIMENTAL
Intervention: Isoproterenol infusion
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Insulin infusion (8 and 40 mU/m2/min)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (AGA)
Number of subjects: 46
Study: 12486865

Group type: EXPERIMENTAL
Intervention: 5-methyltetrahydrofolate (400 micrograms day-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Folic acid (400 micrograms day-1)
Number of subjects: 20
Study: 9657560

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Montelukast 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Montelukast 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Montelukast (pooled 10 and 50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7667645

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (MTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 0
Study: 2696322

Group type: EXPERIMENTAL
Intervention: Occlusive clothing (shirts and trousers impervious to bacteria)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ultraviolet radiation
Number of subjects: 20
Study: 1155062

Group type: EXPERIMENTAL
Intervention: Glucagon 300 mug/kg i.m. (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glucagon 300 mug/kg i.v. (Group C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Group A)
Number of subjects: 30
Study: 29439358

Group type: EXPERIMENTAL
Intervention: Directed visual training
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Undirected visual training
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Visual training (both directed and undirected)
Number of subjects: 35
Study: 28108927

Group type: EXPERIMENTAL
Intervention: smalltalk group-only (toddler trial)
Number of subjects: 2186

Group type: EXPERIMENTAL
Intervention: smalltalk plus (toddler trial)
Number of subjects: 2186

Group type: EXPERIMENTAL
Intervention: smalltalk plus (infant trial)
Number of subjects: 2186

Group type: COMPARATOR
Intervention: standard program (control for toddler trial)
Number of subjects: 2186

Group type: COMPARATOR
Intervention: standard/usual practice controls (infant trial)
Number of subjects: 2186
Study: 26022961

Group type: EXPERIMENTAL
Intervention: Sham CPAP
Number of subjects: 59

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 59
Study: 23206377

Group type: EXPERIMENTAL
Intervention: Item banks for alcohol use
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Item banks for negative consequences of alcohol use
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Item banks for positive consequences of alcohol use
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Item banks for negative expectancies regarding drinking
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Item banks for positive expectancies regarding drinking
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Seven-item static short forms from each item bank
Number of subjects: 1407
Study: 21621722

Group type: EXPERIMENTAL
Intervention: Cervical spine manipulation targeted to C5/C6 segment
Number of subjects: 37
Study: 19171507

Group type: EXPERIMENTAL
Intervention: Radio-guided occult lesion localization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wire-guided localization
Number of subjects: 0
Study: 16318177

Group type: EXPERIMENTAL
Intervention: Electro-optic device mounted on a slit lamp to assess the degree of polarization of a light beam.
Number of subjects: 0
Study: 12242597

Group type: EXPERIMENTAL
Intervention: Ibuprofen arginate 200 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Ibuprofen arginate 400 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Ibuprofen arginate 200 mg and 400 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg and 400 mg
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 10355678

Group type: EXPERIMENTAL
Intervention: Drawings of tools (man-made objects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drawings of animals and fruit (natural objects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing and matching unfamiliar non-objects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coloured stimuli for identification (natural objects)
Number of subjects: 0
Study: 10155618

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study: 1683602

Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Bucindolol (ISCDC subgroup)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Bucindolol (IDC subgroup)
Number of subjects: 49
Study: 6812301

Group type: EXPERIMENTAL
Intervention: 60 mg diltiazem t.i.d.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 90 mg diltiazem t.i.d. (after dose increase)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine t.i.d.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine t.i.d.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Long-term treatment with diltiazem (60 mg or 90 mg t.i.d.)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Diltiazem vs. Nifedipine
Number of subjects: 43
Study: 31290981

Group type: EXPERIMENTAL
Intervention: Hydrocortisone replacement therapy at doses of 10, 20, or 30 mg/d for 4 weeks per term for three terms
Number of subjects: 70
Study: 27435493

Group type: EXPERIMENTAL
Intervention: Conventional osseous resective surgery (ORS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fibre retention osseous resective surgery (FibReORS)
Number of subjects: 13
Study: 26192235

Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation with the TRUCLEAR 8.0 Tissue Removal System
Number of subjects: 84

Group type: COMPARATOR
Intervention: Bipolar resectoscopy with a rigid 8.5-mm bipolar resectoscope
Number of subjects: 84
Study: 25490908

Group type: EXPERIMENTAL
Intervention: Adequately randomized trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inadequately randomized trials
Number of subjects: 0
Study: 22658378

Group type: EXPERIMENTAL
Intervention: ixabepilone 40 mg/m² on day 1 plus capecitabine 1000 mg/m² BID on days 1 to 14
Number of subjects: 1973

Group type: COMPARATOR
Intervention: No/late dose reduction of ixabepilone
Number of subjects: 1973
Study: 19303972

Group type: EXPERIMENTAL
Intervention: Equidominant meal (1:1:1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acid (PUFA)-dominant meal (PUFA-D, 1:1.7:2.3)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Monounsaturated fatty acid (MUFA)-dominant meal (MUFA-D, 1:1.7:1.2)
Number of subjects: 28
Study: 17369599

Group type: EXPERIMENTAL
Intervention: Low-bacterial diet (LBD) with antimicrobial prophylaxis (AP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal hospital diet (NHD) with antimicrobial prophylaxis (AP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-bacterial diet (LBD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal hospital diet (NHD)
Number of subjects: 0
Study: 15446406

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Bioresorbable membrane (GTR)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combination of EMD and GTR
Number of subjects: 9
Study: 11432891

Group type: EXPERIMENTAL
Intervention: Cetuximab (loading dose of 100 to 500 mg/m², followed by weekly infusions of 100 to 250 mg/m² for 7 to 8 weeks) + Radiation Therapy (RT) (70 Gy, 2 Gy/d or hyperfractionated RT 76.8 Gy, 1.2 Gy bid)
Number of subjects: 16
Study: 9537429

Group type: EXPERIMENTAL
Intervention: Lanreotide 50 microg/h
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lanreotide 100 microg/h
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lanreotide 200 microg/h
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lanreotide (all doses)
Number of subjects: 8
Study: 7702357

Group type: EXPERIMENTAL
Intervention: Intravenous cibenzoline administered as a 2 minute bolus at a dose of 1.2 mg.kg‐1
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intravenous cibenzoline administered as a 10 minute infusion at a dose of 1.75 mg.kg‐1
Number of subjects: 62
Study: 2596434

Group type: EXPERIMENTAL
Intervention: 390 mg ferrous sulfate/d for 2 months
Number of subjects: 412

Group type: COMPARATOR
Intervention: Hemoglobin
Number of subjects: 412
Study: 240780

Group type: EXPERIMENTAL
Intervention: Rimiterol (0.5 mug/kg/min high dose)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Salbutamol (0.3 mug/kg/min high dose)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isoprenaline (0.05 mug/kg/min high dose)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rimiterol and Isoprenaline
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isoprenaline (compared to rimiterol and salbutamol)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Equal bronchodilator action
Number of subjects: 7
Study: 30981696

Group type: EXPERIMENTAL
Intervention: Alectinib (600 mg twice daily)
Number of subjects: 187
Study: 29032007

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 90
Study: 25040957

Group type: EXPERIMENTAL
Intervention: Cancer-related fatigue
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Age-related fatigue reporting
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 120
Study: 23861324

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFM) for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study: 21675275

Group type: EXPERIMENTAL
Intervention: Proxodolol (120 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Carvedilol (25 mg)
Number of subjects: 60
Study: 19330596

Group type: EXPERIMENTAL
Intervention: 3-word test
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 3-picture test
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Free recall
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Long delay reproduction (24 hours)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Memory test with free recall of words after a long delay
Number of subjects: 112
Study: 16926835

Group type: EXPERIMENTAL
Intervention: Oral paclitaxel (SMEOF#3) 160 mg + CsA 700 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Oral paclitaxel (Taxol) 160 mg + CsA 700 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Intravenous paclitaxel (Taxol) 160 mg
Number of subjects: 7
Study: 15228716

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg/child)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Albendazole (400 mg/child) + Praziquantel (20 mg/kg)
Number of subjects: 20
Study: 11782039

Group type: EXPERIMENTAL
Intervention: Internal pilot study design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blinded sample size recalculation procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study designs allowing for early stopping
Number of subjects: 0